Search
CAMP4 Therapeutics Corp
CAMPAdd to Watchlist
4.430USD
+0.090+2.07%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
230.03MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of CAMP4 Therapeutics Corp is 8.67, ranking 75 out of 387 in the Biotechnology & Medical Research industry. The average price target is 7.50, with a high of 12.00 and a low of 7.00.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
8.500
Target Price
+95.85%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
CAMP4 Therapeutics Corp
CAMP
7
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is CAMP4 Therapeutics Corp's expected revenue for the next quarter?
CAMP4 Therapeutics Corp's expected revenue is 1.90M.
What is CAMP4 Therapeutics Corp's price target?
Analysts forecast that CAMP4 Therapeutics Corp's price target is USD 7.50, with the highest forecast at USD 12.00 and the lowest forecast at USD 7.00.
How have CAMP4 Therapeutics CorpCAMP's recent earnings per share performed?
The market expectation was USD -0.32, while CAMP4 Therapeutics CorpCAMP's earnings per share (EPS) for the previous quarter was USD -0.75. EPS for the next quarter is expected at USD -0.21.
What is the analyst rating for CAMP4 Therapeutics Corp?
Based on the ratings of CAMP4 Therapeutics Corp's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.